Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mai H. ElNaggar, Abdullah A. Elgazar, Ghada Gamal, Shimaa M. Hamed, Zainab M. Elsayed, Mohamed K. El-Ashrey, Amira Abood, Mahmoud A. El Hassab, Ahmed M. Soliman, Ramadan A. El-Domany, Farid A. Badria, Claudiu T. Supuran & Wagdy M. Eldehna. (2023) Identification of sulphonamide-tethered N-((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Baohui Zhu, Ryota Ouda, Paul de Figueiredo & Koichi S Kobayashi. (2023) ORF6, a repressor of the MHC class I pathway: new molecular target for SARS-CoV-2 drug discovery?. Expert Opinion on Therapeutic Targets 27:8, pages 639-644.
Read now
Read now
Articles from other publishers (2)
Ahmed A. Al-Karmalawy, Mai H. A. Mousa, Marwa Sharaky, Mai A. E. Mourad, Ahmed M. El-Dessouki, Amir O. Hamouda, Radwan Alnajjar, Abdelmoneim A. Ayed, Moataz A. Shaldam & Haytham O. Tawfik. (2023) Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical Assessments. Journal of Medicinal Chemistry 67:1, pages 492-512.
Crossref
Crossref
Saad Shaaban, Ahmed A. Al-Karmalawy, Abdulrahman G. Alhamzani, Mortaga M. Abou–Krisha, Mahmoud A. Al–Qudah & Tarek A. Yousef. (2023) Synthesis and Molecular Docking Analysis of New Thiazo-isoindolinedione Hybrids as Potential Inhibitors of the SARS-CoV-2 Main Protease. Oriental Journal Of Chemistry 39:4, pages 913-918.
Crossref
Crossref